Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

Pigment Cell & Melanoma Research(2020)10.1111/pcmr.12861Source: DataRank Database

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions is a research paper published in Pigment Cell & Melanoma Research (2020). On theSindex it has a DataRank of 0. It has been cited 56 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access56 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.72)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Keiran S.M. Smalley ORCID,Priscilla K. Brastianos ORCID,Michael A. Davies ORCID,Ian E. McCutcheon ORCID,James K. Liu ORCID

Live enrichment

PubMed:31916400 PMC:PMC10126834 OpenAlex:https://openalex.org/W3000673995

NCI NIH HHS

Grant: R01 CA245499

NCI NIH HHS

Grant: R01 CA244975

FWCI

4.72

Citation Percentile

1.0%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10126834/pdf/nihms-1893662.pdf

BRONZEhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/pcmr.12861

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10126834/pdf/nihms-1893662.pdf

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fpcmr.12861

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/pcmr.12861

Fields of Study

Brain Metastases and TreatmentGlioma Diagnosis and TreatmentMelanoma and MAPK PathwaysMedicineCell-Free Nucleic AcidsClinical Trials as TopicHumansMelanomaMeningeal NeoplasmsMolecular Targeted TherapyNeoplastic Cells, Circulating

MeSH Terms

Cell-Free Nucleic AcidsClinical Trials as TopicHumansMelanomaMeningeal NeoplasmsNeoplastic Cells, CirculatingMolecular Targeted Therapy

Keywords

SummitMelanomaMedicineDiseaseTranslational researchCancerBasic researchIntensive care medicineCancer researchPathologyInternal medicineLibrary scienceComputer scienceNeoplastic MeningitisLeptomeningeal CarcinomatosisIntrathecal TherapyLeptomeningeal Disease

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (2)

Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

N/A

2.5DataRank · unranked

Journal for ImmunoTherapy of Cancer(2021)

co-cited

10.1136/jitc-2021-002473

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

N/A

1.9DataRank · unranked

Nature Medicine(2023)

co-cited

10.1038/s41591-022-02170-x

Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions

FAIR Checklist

Authors (18)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)